Jean-François Borel
   HOME

TheInfoList



OR:

Jean-François Borel (born 4 July 1933 in
Antwerp Antwerp (; ; ) is a City status in Belgium, city and a Municipalities of Belgium, municipality in the Flemish Region of Belgium. It is the capital and largest city of Antwerp Province, and the third-largest city in Belgium by area at , after ...
,
Belgium Belgium, officially the Kingdom of Belgium, is a country in Northwestern Europe. Situated in a coastal lowland region known as the Low Countries, it is bordered by the Netherlands to the north, Germany to the east, Luxembourg to the southeas ...
) is a Belgian
microbiologist A microbiologist (from Greek ) is a scientist who studies microscopic life forms and processes. This includes study of the growth, interactions and characteristics of microscopic organisms such as bacteria, algae, fungi, and some types of par ...
and immunologist who is considered one of the discoverers of
cyclosporin Ciclosporin, also spelled cyclosporine and cyclosporin, is a calcineurin inhibitor, used as an immunosuppressant medication. It is taken orally or intravenously for rheumatoid arthritis, psoriasis, Crohn's disease, nephrotic syndrome, ecz ...
.


Early life

Borel studied at the
University of Antwerp The University of Antwerp () is a major Belgian university located in the city of Antwerp. The official abbreviation is ''UAntwerp''. The University of Antwerp has about 20,000 students, which makes it the third-largest university in Flanders. ...
and the
ETH Zurich ETH Zurich (; ) is a public university in Zurich, Switzerland. Founded in 1854 with the stated mission to educate engineers and scientists, the university focuses primarily on science, technology, engineering, and mathematics. ETH Zurich ran ...
, where he received his doctorate in immunological genetics in 1964. Afterwards he was at the Swiss Research Institute of Medicine. From 1970 he was in the research laboratories of
Sandoz Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the ...
in
Basel Basel ( ; ), also known as Basle ( ), ; ; ; . is a city in northwestern Switzerland on the river Rhine (at the transition from the High Rhine, High to the Upper Rhine). Basel is Switzerland's List of cities in Switzerland, third-most-populo ...
.


Discovery of cyclosporin

In 1972, Borel was involved in the discovery of the
immunosuppressive Immunosuppression is a reduction of the activation or efficacy of the immune system. Some portions of the immune system itself have immunosuppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse react ...
effects of cyclosporin (Sandoz called Sandimmun), which was isolated by Sandoz in 1971 from a fungus that a Sandoz employee brought back from vacation in Norway. The screening program at Sandoz was previously developed by K. Saameli (and Stähelin) and the immunological testing procedures of S. Lazary. Initially, use as an antibiotic was considered. When it was realized that the substance had only
T-cells T cells (also known as T lymphocytes) are an important part of the immune system and play a central role in the adaptive immune response. T cells can be distinguished from other lymphocytes by the presence of a T-cell receptor (TCR) on their cell ...
and therefore had potential in transplantation medicine, Borel aroused much attention in 1976 at a congress in London. In the practice of organ transplantation, the new drug was tested in 1977 by the British surgeon Roy Yorke Calne. In 1983, Borel became vice president of the pharmaceutical division of Sandoz (later
Novartis Novartis AG is a Swiss multinational corporation, multinational pharmaceutical company, pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by re ...
). Since 1981 he was Professor of Immunopharmacology at the
University of Bern The University of Bern (, , ) is a public university, public research university in the Switzerland, Swiss capital of Bern. It was founded in 1834. It is regulated and financed by the canton of Bern. It is a comprehensive university offering a br ...
. Also involved in the discovery and development was Hartmann Stähelin, head of the Pharmacology Department at Sandoz, which included the Immunology Department, and later there was a dispute over their respective shares in the discovery.


Awards

* 1984:
Cloëtta Prize The Cloëtta Prize (; ) is a Swiss distinction to honour personalities who have distinguished themselves in biomedical research. Worth 50,000 Swiss francs, it has been awarded annually by the Max Cloëtta Foundation (based in Zurich), since 19 ...
* 1985: J. Allyn Taylor International Prize in Medicine * 1986:
Gairdner Foundation International Award The Canada Gairdner International Award is given annually by the Gairdner Foundation at a special dinner to five individuals for outstanding discoveries or contributions to medical science. Receipt of the Gairdner is traditionally considered a ...
* 1987:
Paul Ehrlich and Ludwig Darmstaedter Prize The Paul Ehrlich and Ludwig Darmstaedter Prize is an annual award bestowed by the since 1952 for research in medicine. It carries a monetary prize of 120,000 Euro. The prize ceremony is traditionally held on the 14th of March, the birthday of Nob ...
* 1993: InBev-Baillet Latour Health Prize * 1991 he became an honorary doctor in Basel.


See also

Organ transplantation Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be trans ...


References

1933 births Living people Belgian pharmacologists ETH Zurich alumni {{belgium-scientist-stub